COMPARATIVE ANALYSIS OF THYROID FUNCTION PROFILES BETWEEN POLYCYSTIC OVARY SYNDROME PATIENTS AND HEALTHY CONTROLS: A COMPREHENSIVE STUDY

Authors

  • Amandeep Kaur Professor, Department of Biochemistry, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India.
  • Tejinder Singh Medical Officer, Army Medical Corps., India.
  • Komalpreet Kaur Demonstrator, Department of Biochemistry, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India.
  • Sukhjeet Kaur Demonstrator, Department of Biochemistry, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India.

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i3.50525

Keywords:

Polycystic ovarian syndrome, thyroid function test, Body mass index, Insulin resistance.

Abstract

Objective: To assess the thyroid function status of patients with Polycystic Ovary Syndrome (PCOS) and to compare it with that of healthy women.

Methods: This was a descriptive cross-sectional study conducted in the Department of Biochemistry in collaboration with the Department of Obstetrics and Gynecology of a tertiary care hospital in Northern India. 30 patients diagnosed to have polycystic ovarian syndrome on the basis of the Rotterdam criteria were included in this study as cases (Group P). 30 healthy women were enrolled as the control group (Group H). The mean age and marital status of the patients were assessed. The body mass index of all the patients was also determined and compared. Systolic blood pressure, diastolic blood pressure, and pulse rate were also compared. A thyroid function test was done in both groups. The mean triiodothyronine (T3), T4, and thyroid-stimulating hormone (TSH) levels were compared in both groups. p<0.05 was taken as statistically significant.

Results: The mean age of patients with PCOS and healthy individuals was 22.10±3.97 years and 23.76±3.97 years, respectively. The mean ages of both groups were found to be comparable in both studies (p=0.1108). The mean body mass index (BMI) of groups P and H was found to be 27.23±5.82 and 23.15±4.12, respectively. The women in group P were found to have a higher BMI as compared to women in group H, and the difference was found to be statistically significant (p=0.0027). The mean pulse rate, systolic blood pressure, and diastolic blood pressure values were found to be comparable. The mean FT3 levels in groups P and H were found to be 3.11±0.88 and 3.13±0.42 ng/mL, whereas the mean free thyroxine levels in groups P and H were found to be 0.96±0.16 and 0.89±0.15, respectively, μg/dL. The mean T3 and T4 levels of both groups were found to be comparable in both groups. However, the mean TSH level in groups P and H was found to be 4.95±2.24 and 2.50±1.19 0.3–4.5 μIU/ml, respectively. The mean TSH level in group P was found to be higher than group H, and the difference was found to be statistically significant (p<0.001).

Conclusion: The prevalence of subclinical hypothyroidism was found to be significantly high in women with PCOS, making it necessary to do periodic thyroid function tests in PCOS.

 

Downloads

Download data is not yet available.

References

Wang R, Mol BW. The Rotterdam criteria for polycystic ovary syndrome: Evidence-based criteria? Hum Reprod 2017;32:261-4. doi: 10.1093/humrep/dew287

Cooney LG, Dokras A. Beyond fertility: Polycystic ovary syndrome and long-term health. Fertil Steril 2018;110:794-809. doi: 10.1016/j. fertnstert.2018.08.021

Moghetti P. Insulin resistance and polycystic ovary syndrome. Curr Pharm Des 2016;22:5526-34. doi: 10.2174/1381612822666160720155855

Fan H, Ren Q, Sheng Z, Deng G, Li L. The role of the thyroid in polycystic ovary syndrome. Front Endocrinol (Lausanne) 2023;14:1242050. doi: 10.3389/fendo.2023.1242050

Palomba S, Colombo C, Busnelli A, Caserta D, Vitale G. Polycystic ovary syndrome and thyroid disorder: A comprehensive narrative review of the literature. Front Endocrinol (Lausanne) 2023;14:1251866. doi: 10.3389/fendo.2023.1251866

Srivastava S, Mathur G, Chauhan G, Kapoor P, Bhaskar P, Jain G, et al. Impact of thyroid dysfunction on insulin resistance: A study from a tertiary care center in India. J Assoc Physicians India 2021;69:49-53.

Saran S, Gupta SB, Philip R, Singh SK, Bende AS, Agroiya P, et al. Effect of hypothyroidism on female reproductive hormones. Indian J Endocrinol Metab 2016;20:108-13. doi: 10.4103/2230-8210.172245

De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: An update. Reprod Biol Endocrinol 2016;14:38. doi: 10.1186/s12958-016-0173-x

Farland LV, Stern JE, Liu CL, Cabral HJ, Coddington CC, Diop H, et al. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: A registry linkage study from Massachusetts. Hum Reprod 2022;37:2690-9. doi: 10.1093/humrep/deac210

Collee J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: Overview and insights of the putative treatments. Gynecol Endocrinol 2021;37:869-74. doi: 10.1080/09513590.2021.1958310

Dittrich R, Kajaia N, Cupisti S, Hoffmann I, Beckmann MW, Mueller A. Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. Reprod Biomed Online 2009;19:319-25. doi: 10.1016/S1472-6483(10)60165-4

Kedar KV, Rewatkar MM, Akare MD. Thyroid dysfunction in women with polycystic ovarian syndrome: A comparative study. Int J Reprod Contracept Obstet Gynecol 2019;8:1943-5.

Yuan C, Liu X, Mao Y, Diao F, Cui Y, Liu J. Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: A prospective study. J Biomed Res 2016;30:197-202. doi: 10.7555/JBR.30.20140111

Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2021;95:531-41. doi: 10.1111/cen.14421

Kumari G, Kumari R, Nawaz M. Study of BMI and waist/hip ratio in PCOS cases in Jharkhand: J Cardio Dis Res 2023;14:3201-6.

Naderpoor N, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ. Obesity and polycystic ovary syndrome. Minerva Endocrinol 2015;40:37-51.

Sam S. Obesity and polycystic ovary syndrome. Obes Manag 2007;3:69-73. doi: 10.1089/obe.2007.0019

Ding X, Yang L, Wang J, Tang R, Chen Q, Pan J, et al. Subclinical hypothyroidism in polycystic ovary syndrome: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 2018;9:700. doi: 10.3389/ fendo.2018.00700

Ganie MA, Laway BA, Wani TA, Zargar MA, Nisar S, Ahamed F, et al. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome. Fertil Steril 2011;95:2039-43. doi: 10.1016/j. fertnstert.2011.01.149

Benetti-Pinto CL, Berini Piccolo VR, Garmes HM, Teatin Juliato CR. Subclinical hypothyroidism in young women with polycystic ovary syndrome: An analysis of clinical, hormonal, and metabolic parameters. Fertil Steril 2013;99:588-92. doi: 10.1016/j.fertnstert.2012.10.006

Published

07-03-2024

How to Cite

Kaur, A., T. Singh, K. Kaur, and S. Kaur. “COMPARATIVE ANALYSIS OF THYROID FUNCTION PROFILES BETWEEN POLYCYSTIC OVARY SYNDROME PATIENTS AND HEALTHY CONTROLS: A COMPREHENSIVE STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 3, Mar. 2024, pp. 29-32, doi:10.22159/ajpcr.2024.v17i3.50525.

Issue

Section

Original Article(s)

Most read articles by the same author(s)